Vedolizumab PB016

vedolizumab · Polpharma Biologics S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vedolizumab PB016, covering 2025-06-17 to 2025-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® [Phase 3]

See pricing